Clinical Trials Directory

Trials / Completed

CompletedNCT00753428

Community-based Evaluation of a Pilot PMTCT Project in Kafue District

CIDRZ 1236 - Community-based Evaluation of a Pilot PMTCT Project in Kafue District: Impact of HAART to Prevent Pediatric AIDS in Rural Zambia.

Status
Completed
Phase
Study type
Observational
Enrollment
4,129 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

In this study, the investigators will assess the population effectiveness of using routine HAART as a PMTCT strategy, through a community-based survey. The survey will be done in the catchment areas of four health clinics in rural Zambia both before and after giving routine ART in the clinics, so as to estimate population HIV-free survival among infants born in each target community. The investigators hypothesize that incorporation of routine ART into PMTCT will increase the HIV-free survival of exposed infants to 75%.

Detailed description

The primary objective is to determine the incremental benefit of a routine ART strategy for PMTCT on a population basis, when compared to short-course Zidovudine and single-dose Nevirapine (the current PMTCT standard of care). We will take advantage of planned implementation of a pilot project for routine ART across four primary care centres in rural Zambia (Kafue District). Using a community-based survey modeled after the Demographic and Health Survey, we will measure HIV-free survival among children under two years of age in the catchment areas surrounding these pilot sites, both before and after implementation of services. We will use before-after comparisons in each of these four communities to better understand the incremental benefit of providing these services.

Conditions

Interventions

TypeNameDescription
OTHERCommunity-based SurveyQuestionnaires will be used to record detailed information regarding demographic and socioeconomic characteristics, maternal medical history, recent obstetrical history (including access to preventive services for mother-to-child HIV transmission), and infant medical history. Infant deaths will also be recorded as part of the survey. In cases where either the mother or infant has died, we will perform verbal autopsy interviews (Appendix 5) with surviving family members to determine cause of death and gather information regarding HIV infection and/or exposure. Heel/finger pricks will be taken so as to perform dried blood spot cards, and test for HIV in children and adults.

Timeline

Start date
2008-11-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2008-09-16
Last updated
2018-04-19

Locations

1 site across 1 country: Zambia

Source: ClinicalTrials.gov record NCT00753428. Inclusion in this directory is not an endorsement.